Advent Life Sciences LLP 13D/13G Filings for Eloxx Pharmaceuticals, Inc. (ELOX)

Advent Life Sciences LLP 13D and 13G filings for Eloxx Pharmaceuticals, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime		 Transaction
Date		 Type Company
Symbol		 Filed By
Symbol		 Shares Owned
% Owned		 Shares Vs. Prev Report View
2024-08-20
8:13 pm
Purchase		 2024-08-20 13D Eloxx Pharmaceuticals, Inc.
ELOX		 Advent Life Sciences LLP 124,972
3.980%		 61,665increase
(+97.41%)		 Filing
2021-04-13
2:05 pm
Purchase		 2021-04-01 13D Eloxx Pharmaceuticals, Inc.
ELOX		 Advent Life Sciences LLP 63,307
6.300%		 63,307increase
(New Position)		 Filing